Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-25-009629

PRESIDENT AND CEO gave up 30,498 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Domzalski David PRESIDENT AND CEO 2025-03-31 Shares withheld for taxes −30,498 $1.58 $48,187 445,563 D: show line 1 in the form
Loading xslF345X05/form4-04022025_040405.xml…